Stryker (Juvenile Tumor System) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Stryker (Juvenile Tumor System) General Information

Description

Enabler of limb stabilization and growth in pediatric patients affected by bone cancers and malignant diseases. It non-invasively lengthens the implant post-surgery in a clinical setting and removes the need for multiple lengthening surgeries, anesthesia, or sedation to reduce complication risk and limb reconstruction surgery costs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2825 Airview Boulevard
  • Kalamazoo, MI 49002
  • United States
Primary Industry
Surgical Devices
Acquirer
Onkos Surgical
Vertical(s)
Oncology
Corporate Office
  • 2825 Airview Boulevard
  • Kalamazoo, MI 49002
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stryker (Juvenile Tumor System) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stryker (Juvenile Tumor System)‘s full profile, request access.

Request a free trial

Stryker (Juvenile Tumor System) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Stryker (Juvenile Tumor System)‘s full profile, request access.

Request a free trial

Stryker (Juvenile Tumor System) FAQs

  • Where is Stryker (Juvenile Tumor System) headquartered?

    Stryker (Juvenile Tumor System) is headquartered in Kalamazoo, MI.

  • What industry is Stryker (Juvenile Tumor System) in?

    Stryker (Juvenile Tumor System)’s primary industry is Surgical Devices.

  • Is Stryker (Juvenile Tumor System) a private or public company?

    Stryker (Juvenile Tumor System) is a Private company.

  • What is Stryker (Juvenile Tumor System)’s current revenue?

    The current revenue for Stryker (Juvenile Tumor System) is .

  • Who are Stryker (Juvenile Tumor System)’s investors?

    Stryker has invested in Stryker (Juvenile Tumor System).

  • When was Stryker (Juvenile Tumor System) acquired?

    Stryker (Juvenile Tumor System) was acquired on 03-Jun-2022.

  • Who acquired Stryker (Juvenile Tumor System)?

    Stryker (Juvenile Tumor System) was acquired by Onkos Surgical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process